New drug designed to prevent chronic migraines

The U-S Food and Drug Administration has approved a new drug said to be the first designed to prevent chronic migraines.

Aimovig is a monthly shot developed by American drug maker Amgen and drug giant Novartis AG, and will cost almost seven-thousand dollars a year without insurance.

Current prevention treatments include pills originally developed for epilepsy and other conditions and the wrinkle reducer Botox, but many patients abandon them because they don’t help much or cause serious side effects.

Posted in News & Sports

AM 1380 @iHeart Radio

+ Follow Us

 

Upcoming Events

  1. Waterford Legion August Events

    August 9 @ 7:30 pm - August 30 @ 7:00 pm
  2. CHHA FUNdraising Golf Tournament

    September 7 @ 4:00 pm - 8:30 pm
  3. Kidney Walk

    September 22 @ 9:00 am

+ On-Air & Shows